• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Filana Therapeutics Releases 2025 Full-Year Financial Results

    GLOBENEWSWIRE

    Filana Leaves Cassava Roots Behind Amid Branch Into Epilepsy

    FIERCE PHARMA

    Cassava Announces Closure of Department of Justice Investigation

    GLOBENEWSWIRE

    Cassava Publishes Simufilam Phase 3 Results In Alzheimer Disease

    GLOBENEWSWIRE

    Cassava Unveils Q3 2025 Financials & Business Update

    GLOBENEWSWIRE

    Cassava Sciences Appoints Dawn C. Bir To The Board Of Directors

    GLOBENEWSWIRE

    Cassava Sciences Joins H.C. Wainwright Global Investment

    GLOBENEWSWIRE

    Cassava Reports Q2 2025 Financial Results, Business Update

    GLOBENEWSWIRE

    Cassava Sciences touts positive preclinical study on Simufilam

    GLOBENEWSWIRE

    Cassava Appoints Anglique Bordey, PhD, to Enhance TSC Program

    GLOBENEWSWIRE

    Cassava Sciences Provides a Business Update

    GLOBENEWSWIRE

    Cassava flunks phase 3 Alzheimer`s test, stops 2nd trial

    FIERCE BIOTECH

    Cassava Sciences to Hold Corporate Update on November 25th

    GLOBENEWSWIRE

    Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

    GLOBENEWSWIRE

    Cassava Sciences Reports Q3 2024 Financial & Operating Results

    GLOBENEWSWIRE

    Cassava Sciences to Report Q3 2024 Results on November 7, 2024

    GLOBENEWSWIRE

    Cassava Sciences Resolves SEC Investigation

    GLOBENEWSWIRE

    Cassava Sciences Completes Interim Review of Simufilam Phase 3

    GLOBENEWSWIRE

    Cassava Sciences Names Rick Barry as Chief Executive Officer

    GLOBENEWSWIRE

    Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

    GLOBENEWSWIRE

    Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates

    GLOBENEWSWIRE

    Cassava Sciences To Hold Update Call On August 8

    GLOBENEWSWIRE

    Cassava hints `short-sellers` to blame for leaking CUNY report

    FIERCE BIOTECH

    Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.